OMCL

Omnicell (OMCL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Investors with an interest in Medical Info Systems stocks have likely encountered both Omnicell (OMCL) and Veeva Systems (VEEV). But which of these two companies is the best option for those looking for undervalued stocks?

Robotics is poised for robust long-term growth. Consider OMCL, SNPS, CDNS and MCHP for potential market dominance across sectors.

HTO, CR and OMCL made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 5, 2026.

The consensus price target hints at a 40.8% upside potential for Omnicell (OMCL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

HTO, SWKS, OMCL, CR and EXPD have been added to the Zacks Rank #1 (Strong Buy) List on November 5, 2026.

HTO, and OMCL made it to the Zacks Rank #1 (Strong Buy) value stocks list on November 5, 2026.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Omnicell NASDAQ: OMCL reported third-quarter 2026 revenue and non-GAAP EBITDA above the high end of its prior guidance, while executives said the company is preparing to begin shipments of its Titan XT automated dispensing hardware and remains on track for first-half 2027 general availability of its OmniSphere cloud platform.

While the top- and bottom-line numbers for Omnicell (OMCL) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.